What it is
Psychotherapy that helps you make sense of a past psychedelic experience. No substances are involved.
Emerging evidence
Psychedelic Integration Therapy
The experience is just the beginning, integration is where lasting transformation happens.
CategoryComplementary
SafetyLow risk
Reviewed by Gyfts Editorial Team · Editorial Health Review
6 July 2026
At a glance
Psychedelic Integration Therapy at a glance
Why explore it
Some people use it to process intense or confusing experiences and carry insights into daily life.
How it’s experienced
Confidential, nonjudgmental conversations about what you saw, felt, and thought.
Evidence context
Evidence for integration itself is emerging, drawing on wider psychedelic-assisted therapy research.
See the evidence snapshotSafety
Low risk since no substance is given. Choose a credentialed therapist.
See staying safeHistory & Origin
About Psychedelic Integration Therapy
Psychedelic integration therapy is a form of psychotherapy that helps people make sense of an experience with a psychedelic substance, whether it happened in a clinical trial, a legal ceremony, or elsewhere. The therapist does not provide or administer any substance. The work is conversation and reflection.
Sessions are confidential, nonjudgmental conversations in which you talk through what you saw, felt, and thought, including the difficult or confusing parts. The therapist may draw on familiar methods such as mindfulness, somatic awareness, journaling, or creative work to help you ground what emerged and think about what it means for daily life. Many people meet over several weeks.
People seek it to process a challenging experience, find meaning in an insight, steady themselves after feeling disoriented or overwhelmed, support behavior change, or prepare for and follow up after a clinical or ceremonial experience. Practitioners describe integration as helping people bring what they learned into relationships, work, and habits.
The evidence is emerging. Integration is built into the structure of major clinical trials of psychedelic-assisted therapy, and professionals widely regard it as important, but research that tests integration therapy on its own is limited. It draws on well-studied talking therapy skills, and results vary from person to person.
Because it involves no substance, integration therapy is generally lawful to offer. Look for a licensed therapist with training in psychedelic-informed care. If you are in acute distress, have thoughts of harming yourself, or a history of psychosis, contact emergency services or a mental health professional promptly. It complements medical and mental health care, not replaces it.
Psychedelic integration therapy emerged as a distinct specialty in the 2010s, but it builds on a longer history. The psychiatrist Humphry Osmond coined the word psychedelic in 1957, and researchers in the 1950s and 1960s, including Stanislav Grof, studied LSD and related substances in clinical settings. Research largely stopped after the Controlled Substances Act of 1970 placed LSD and psilocybin in Schedule I in the United States. Rick Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986 to revive that work.
Clinical research resumed in the 2000s, including Roland Griffiths' psilocybin studies at Johns Hopkins, the first of which was published in 2006, and Imperial College London opened its Center for Psychedelic Research in 2019. The trial protocols included preparation and integration sessions, and the term integration came into wider use through those studies and the training programs that followed. The California Institute of Integral Studies began offering a certificate program in psychedelic-assisted therapies in 2015.
Integration support is now also offered for experiences in legal ceremonial or supervised settings, such as the regulated psilocybin programs begun in Oregon and Colorado. Integration therapists typically hold a conventional counseling, psychotherapy or medical license and add specialized training. Standards differ by country and state, and the field continues to develop alongside changing laws.
Mechanism
How it works
Psychedelic Integration Therapy is generally framed as a guided process for attention, reflection, learning, and emotional integration. Depending on the method, a practitioner may use conversation, imagery, structured exercises, body awareness, or therapeutic techniques to help the person explore patterns and choices. It should not be presented as a standalone solution or a substitute for urgent care, but it may support self-understanding when practiced within an appropriate scope. Integration therapy addresses the gap between having a powerful psychedelic experience and translating its insights into lasting positive change in daily life.
- Shared FocusYou and your practitioner align on goals, boundaries, and what matters most.
- Guided ProcessSessions may use conversation, imagery, or creative tools at your own pace.
- Meaning MakingYou gently explore patterns, feelings, and insights that rise to the surface.
- Stabilizing SupportGrounding and pauses help keep the process feeling safe and manageable.
- Next StepsYour practitioner may suggest reflection, practice, or follow-up as needed.
Your first visit
What to expect from a session
A typical session outline to help you feel prepared
A warm, talk-based session where you and your therapist unpack the meaning of your psychedelic experience and explore how to carry its insights into everyday life.
Welcome and Check-In
Your therapist greets you and takes a few minutes to ask how you've been feeling since your last session or since your psychedelic experience, helping you settle in before any deeper work begins.
Setting the Container
Together you briefly revisit confidentiality and the no-judgment policy around substance use, so you feel fully safe speaking openly about what happened during your experience.
Recounting the Experience
You're invited to share your psychedelic experience in your own words and at your own pace, describing the visuals, emotions, body sensations, or encounters that stood out most to you.
Exploring Difficult Material
Your therapist gently guides you through any confusing, frightening, or emotionally charged moments from the experience, helping you sit with them rather than push them away.
Finding Meaning Together
You and your therapist look for recurring themes, symbols, or emotional threads that emerged during your experience and explore what they might mean in the context of your life.
Bridging Insight to Daily Life
The conversation shifts toward practical application, discussing specific changes, conversations, creative projects, or habits that feel aligned with what your experience revealed.
Grounding and Closing
Your therapist helps you arrive back in the present moment, often with a brief grounding exercise, before summarizing key takeaways and leaving you with something to reflect on before your next session.
The Evidence
Evidence context
What research says about psychedelic integration therapy, its role in clinical protocols, and what remains uncertain.
Overall pictureEmerging evidence
Integration is central to psychedelic therapy — but hard to study alone
Psychedelic integration therapy is an emerging specialty with a growing evidence base drawn from clinical trials where integration sessions are built into the protocol. Separating the therapeutic effect of integration from the substance effect remains a core methodological challenge.
What the research showsIntegration is embedded in major trials, making its independent effect difficult to isolate.
Landmark trials — including psilocybin for depression (Carhart-Harris et al., 2021, NEJM) and MDMA for PTSD (Mitchell et al., 2021, Nature Medicine) — include structured integration sessions as core protocol components. This makes the evidence base robust for the combined approach, but limited for integration therapy as a standalone intervention. Evidence is promising but not yet definitive.
Role in clinical protocolsIntegration sessions are not optional extras — they are considered essential to clinical outcomes.
Across major psychedelic research programmes at Johns Hopkins, Imperial College London, and MAPS, integration is treated as integral rather than supplementary. Gorman et al. (2021, Journal of Psychopharmacology) specifically examined integration in harm reduction contexts, finding it supports better outcomes and reduces adverse psychological effects following difficult experiences.
Where this fits in careIntegration therapy complements — it does not replace — conventional mental health support.
As a complementary modality, integration therapy works alongside existing psychological or psychiatric care. It is not a substitute for professional assessment in cases of severe mental health presentations. Its value lies in providing a specialised space to process experiences that conventional therapy frameworks may not be equipped to address.
Safety and legal considerationsIntegration therapy itself is legal; the substances it addresses may not be.
Integration therapy involves no administration of substances and is legal as a form of psychotherapy in all jurisdictions. Therapists must manage confidentiality carefully regarding disclosure of illegal substance use. This modality is not appropriate as a sole response to substance-induced psychosis, prolonged perceptual disturbances, or severe dissociative states — clear referral pathways to psychiatric care are essential.
Practitioner quality and trainingThe field is growing rapidly — practitioner quality and training vary considerably.
Qualified integration therapists typically hold recognised psychotherapy credentials supplemented by specialised training through programmes such as MAPS, Fluence, Naropa, or the California Institute of Integral Studies. The field lacks universal regulation, so verifying credentials and training background is important. Directories such as Psychedelic Support and the Psychedelic Integration List can assist in finding trained practitioners.
What remains uncertainEvidence is promising but the field is young and methodological challenges are significant.
Because integration is always delivered alongside a substance experience in clinical trials, its independent contribution cannot yet be precisely quantified. Qualitative research consistently highlights its value, but large-scale controlled studies of integration therapy alone are limited. Inflated outcome claims should be viewed with caution — this is an evolving area where the evidence base is still being established.
Safety first
Staying safe
General guidance to help you decide whether this approach is appropriate for you. This is informational only and not a substitute for medical, psychological, or professional advice.
When this may not be suitable
Some situations call for extra care or a different approach. Share any conditions, injuries, or sensitivities with your practitioner before your first session.
See specific guidance
- Integration therapy does not involve the provision or administration of any psychedelic substance. Therapists should hold conventional psychotherapy credentials and additional training in psychedelic-specific protocols. The legal status of psychedelic substances varies by jurisdiction, integration therapy itself is legal everywhere as it is a form of psychotherapy. Therapists must navigate confidentiality carefully, particularly regarding disclosure of illegal substance use.
- Integration therapy is not a substitute for psychiatric care in cases of substance-induced psychosis, prolonged perceptual disturbances (HPPD), or severe dissociative states, appropriate referral pathways should be established. The field is growing rapidly and practitioner quality varies, specialized training through recognized programs (MAPS, Fluence, Naropa, California Institute of Integral Studies) provides quality assurance.
Check with a professional first
If you are pregnant, managing a health condition, recovering from injury or surgery, or taking medication, consult a qualified healthcare professional first.
Choosing a practitioner
Look for clear boundaries, transparent pricing, and practitioners who avoid fear-based claims or pressure to book frequent sessions.
Possible side effects or aftercare
Mild, short-lived effects such as tenderness, tiredness, or temporary soreness can occur. Rest, hydrate, and tell your practitioner how you respond.
For you?
Is this right for you?
A simple, human way to weigh it up. This is general guidance, not personal medical advice — a qualified practitioner can advise on your situation.
May be a good fit if…
- Psychedelic integration therapy may suit people who took part in a clinical psychedelic trial, or had an experience in a legal ceremonial setting, and want help making sense of it afterward. It may also help those processing a difficult experience or ongoing psychological effects from past use, or preparing for an upcoming clinical or legal experience. The evidence is still emerging.
May not be right if…
- People seeking a therapist to provide or facilitate access to psychedelic substances, integration therapists do not supply substances. Those in acute psychiatric crisis requiring immediate stabilization. Individuals who are not comfortable discussing substance use with a therapist. People who have not had psychedelic experiences and are seeking general psychotherapy.
Gyfts is a discovery platform, not a medical provider. Nothing here diagnoses, treats or replaces professional care. In an emergency, contact your local emergency number.
Explore approaches
Related modalities
Other practices people often explore alongside psychedelic integration therapy.
In their words
People often describe it as
reflectivestructuredsupportiveemotionally spaciousclarifyingpacedcollaborativegrounding
Read next
Articles & insights
Before you book
Choosing a practitioner
FAQ
Common questions
Does integration therapy involve taking psychedelics?
No. Integration therapy is entirely a talking and processing therapy. The therapist does not provide, administer, or facilitate access to any psychedelic substance. It is legally practiced worldwide as a form of psychotherapy.
Is integration therapy legal?
Yes. Integration therapy is a form of psychotherapy and is legal in all jurisdictions. The psychedelic substances themselves may be illegal, but providing therapeutic support for processing experiences with them is not.
What if I had a bad trip?
Challenging psychedelic experiences are a primary reason people seek integration therapy. A skilled integration therapist helps you process difficult, frightening, or confusing material therapeutically, reframing it as potentially meaningful psychological content rather than something to suppress.
How many sessions do I need?
This varies. Some people benefit from 3 to 4 sessions for a single experience. Complex experiences, ongoing psychedelic work, or deeper psychological processing may require 8 to 12 sessions or more. Your therapist will help determine an appropriate plan.
What qualifications should an integration therapist have?
Look for a licensed therapist, psychologist, or counselor with conventional psychotherapy credentials, plus additional training in psychedelic-specific protocols through recognized programs such as MAPS, Fluence, CIIS, or Naropa. Ask about their training and experience, and how they handle confidentiality around substance use. Integration therapy is conversation only, so your therapist should never provide or administer any substance.
Can integration therapy help with addiction?
Integration is a key component of psychedelic-assisted addiction treatment protocols (e.g., psilocybin for alcohol dependence). As standalone therapy, it can help individuals process experiences that may contribute to recovery insights.
Will my therapist report my drug use?
Integration therapists operate under standard psychotherapy confidentiality rules. Ethical guidelines in the field emphasise non-judgmental, confidential practice. However, confidentiality limits (mandatory reporting for harm to self or others) still apply as in any therapeutic context.
References
Evidence & Research
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
- Trial of psilocybin versus escitalopram for depression
- MDMA-assisted therapy for severe PTSD: A phase 3 study
- Psychedelic harm reduction and integration: A transtheoretical model for clinical practice
- Patients'' accounts of increased connectedness and acceptance after psilocybin
- Effects of psilocybin-assisted therapy on major depressive disorder
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Find Psychedelic Integration Therapy practitioners you can trust
Browse practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.